Advanced search
Publication Cover
The European Journal of Contraception & Reproductive Health Care Volume 24, 2019 - Issue 6
Submit an article Journal homepage
5,178
Views
6
CrossRef citations to date
0
Altmetric
Opinion

Combined hormonal contraceptives in BRCA gene mutation carriers: why not?

Giovanni GrandiDepartment of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3567-3278
ORCID Icon,
Margaret SammariniDepartment of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy;
,
Maria Chiara Del SavioDepartment of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy;
,
Angela TossDepartment of Surgery, Medical, Dental and Morphological Sciences with Interest in Transplantation, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy
&
Fabio FacchinettiDepartment of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy;
Pages 417-419 | Received 16 Apr 2019, Accepted 18 Jul 2019, Published online: 30 Jul 2019

References

  • Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990;250:1684–1689.
  • Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402–2416.
  • Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, et al. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet. 2008;371:303–314.
  • Iversen L, Fielding S, Lidegaard Ø, et al. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study. BMJ. 2018;362:k3609.
  • Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271–289.
  • World Health Organization. Medical eligibility criteria for contraceptive use. 5th ed. Geneva: WHO; 2015.
  • Curtis KM, Tepper NK, Jatlaoui TC, et al. US medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep. 2016;65:1–103.
  • European Society of Contraception and Reproductive Health. Medical condition: hormonal contraception and breast and ovarian cancer; 2018. [cited 2019 Jul 16]. Available from: https://escrh.eu/wp-content/uploads/2018/10/update_mc_chc_breast_ovarian_cancer_me13-06-notes.pdf
  • Faculty of Sexual and Reproductive Healthcare. UK medical eligibility criteria for contraceptive use (UKMEC). London: FSRH; 2016.
  • Mørch LS, Skovlund CW, Hannaford PC, et al. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med. 2017;377:2228–2239.
  • Iversen L, Sivasubramaniam S, Lee AJ, et al. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study. Am J Obstet Gynecol. 2017;216:580.e1–580.e9.
  • Gaffield ME, Culwell KR, Ravi A. Oral contraceptives and family history of breast cancer. Contraception. 2009;80:372–380.
  • Grandi G, Toss A, Cagnacci A, et al. Combined hormonal contraceptive use and risk of breast cancer in a population of women with a family history. Clin Breast Cancer. 2018;18:e15–e24.
  • Vermeulen RFM, Beurden MV, Korse CM, et al. Impact of risk-reducing salpingo-oophorectomy in premenopausal women. Climacteric. 2017;20:212–221.
  • Moorman PG, Havrilesky LJ, Gierisch JM, et al. Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol. 2013;31:4188–4198.
  • Jernström H, Loman N, Johannsson OT, et al. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing. Eur J Cancer. 2005;41:2312–2320.
  • Anderson GL, Chlebowski RT, Aragaki AK, et al. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. Lancet Oncol. 2012;13:476–486.
  • American Cancer Society. 5-year relative survival, 2008–2014, by cancer type; [cited 2019 Jul 16]. Available from: https://cancerstatisticscenter.cancer.org/#!

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.